Opportunities include technological innovation, strategic partnerships, and regional market expansion to enhance operational resilience and modernize supply chains in the evolving blood plasma ...
Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, by prescription, ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback